Longboard Pharma - LBPH Earnings per share for the last twelve months

Longboard Pharmaceuticals Inc (LBPH) - corporate logo

Longboard Pharmaceuticals (LBPH) is demonstrating rapid growth in authority due to its success in treating rare epilepsies. The business relies on developing treatments for severe seizures, which guarantee a stable cash flow. High scientific potential in the CNS field confirms its status as a biopharmaceutical innovator. The rolling annual EPS YoY trend visualizes profitability, where the -0.30 mark serves as the current indicator.

Longboard Pharmaceuticals (LBPH): Net earnings per share (EPS TTM) from 02/11/2024 to 02/20/2024

Longboard Pharmaceuticals, Inc. - analytical breakdowns and key metrics (LBPH)

Product sample of longboardpharma.com

This metric tracks the rate of change in earnings per share over twelve months, reflecting the efficiency of the business's capitalization. The indicator's dynamics allow investors to assess the speed of profit scaling relative to previous periods. For Longboard Pharmaceuticals (LBPH), this calculation depends not on market cycles, but on successes in the development of neurological drugs. An analysis of the rolling earnings per share YoY change on GURU.Markets reveals the fundamental stability of the issuer.

Competitor analysis

Net earnings per share for the trailing year Biogen (BIIB)|neurocrine.com (NBIX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Regencell|AXSM (Axsome) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) ACADIA Pharmaceuticals Inc.|Earnings per share for the last twelve months Xenon Pharmaceuticals (XENE)|VKTX (Viking Pharma) - Earnings per share for the trailing year|Earnings per share for the last twelve months Supernus Corp SUPN|Earnings per share for the last four quarters CPRX (Catalyst Pharmaceuticals)|Denali Therapeutics - Net earnings per share (EPS TTM)|HRMY: Earnings per share for the last twelve months|Biohaven (BHVN) - Earnings per share for the last twelve months|Amylyx Pharmaceuticals Inc (AMLX) - Net earnings per share (EPS TTM)|TRVI (Trevi Therapeutics Inc) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Praxis Medicines (PRAX)|Net earnings per share for the last 12 months AVXL (Anavex Life Sciences)|Net earnings per share for the last 12 months CeriBell CBLL|Earnings per share for the last twelve months Prothena Biosciences PRTA|Net earnings per share (EPS TTM) Alector, Inc. ALEC|ANNX - Earnings per share for the last twelve months|OMER - Net earnings per share (EPS TTM)|Neurogene (NGNE) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months AC Immune SA (ACIU)|Net earnings per share for the last 12 months VYGR|Net earnings per share (EPS TTM) Neumora Therapeutics Inc|Earnings per share for the last twelve months scilexholding.com (SCLX)|Net earnings per share for the last four quarters Tevogen Bio Inc.|Earnings per share for the last twelve months Alpha Cognition Inc. ACOG|Net earnings per share (EPS TTM) Cognition Therapeutics CGTX|IKT: Net earnings per share for the last 12 months|SAVA (Cassava Sciences) - Earnings per share for the last 12 months|Assertio Holdings, Inc. (ASRT) - Earnings per share for the last twelve months|Earnings per share for the last 12 months COYA|Earnings per share for the last twelve months Vistagen|Net earnings per share for the last 12 months Ovid Therapeutics (OVID)|Earnings per share for the last twelve months Acumen Pharmaceuticals Inc. (ABOS)|CRVO - Net earnings per one share for the last twelve months|Alterity Therapeutics Limited - Net earnings per share for the last 12 months|CLNN: Earnings per share for the last 12 months|pepgen.com - Net earnings per share (EPS TTM)|JUNS (Jupiter Neurosciences) - Earnings per share for the last 12 months|Relmada (RLMD) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Annovis Bio (ANVS)|GRCE (gracetx.com) - Net earnings per share (EPS TTM)|Firefly Neuroscience Inc (AIFF) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months KLTO (Klotho Neurosciences Inc)|NeuroSense Therapeutics Ltd - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) RVPH (Reviva Pharmaceuticals, Inc.)|Earnings per share for the trailing year MTVA|NeurAxis Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Helius Medical Technologies, Inc. HSDT|PASG: Net earnings per share (EPS TTM)|Neuphoria (NEUP) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Minerva Neurosciences Inc|Athira Pharma Inc (ATHA) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months ADXN (Addex Therapeutics)|Net earnings per share (EPS TTM) Alzamend Neuro Inc. (ALZN)|Cyclerion Therapeutics, Inc. - Net earnings per share for the last 12 months|PTIX (Protagenic Therapeutics) - Earnings per one share for the last 12 months|Pasithea Therapeutics Corp - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Cortigent CRGT|ATXI (Avenue Therapeutics, Inc) - Net earnings per share for the last 12 months|Brainstorm Cell Therapeutics, Inc. - Earnings per share for the trailing year|Net earnings per share for the last 12 months CARA|Net earnings per one share for the last twelve months chromocell.com CHRO|Earnings per share for the last twelve months Eliem Therapeutics, Inc. (ELYM)|ITCI (Intra-Cellular Therapies, Inc.) - Earnings per share for the trailing year|Marinus Pharmaceuticals Inc - Net earnings per share for the last 12 months|NKGen (NKGN) - Net earnings per one share for the last twelve months|NRBO - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months sagerx.com|SNPX: Net earnings per share (EPS TTM)|Trevena Inc. (TRVN) - Net earnings per share (EPS TTM)|VIGL (Vigil Neuroscience, Inc.) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months WENA (Anew Medical, Inc.)|Net earnings per share (EPS TTM) CERE